Valor202020212022202320242025TTMGastos comerciales, generales y administrativos11.3 B12.35 B15.26 B12.87 B14.75 B14.01 B14.01 BInvestigación y desarrollo7.75 B8.05 B7.21 B8.45 B15.55 B14.11 B14.11 BBeneficio operativo11.36 B17.92 B18.12 B12.76 B9.14 B15.07 B15.07 BTotal de ingresos no operativos-5.51 B-2.51 B-2.41 B-4.28 B-2.61 B-5.58 B-5.64 BGastos por intereses, netos de intereses capitalizados2.45 B2.42 B2.23 B2.22 B2.81 B2.89 B2.89 BIngresos no operativos, una vez deducidos los gastos por intereses-2.35 B-2.44 B-2.19 B-1.83 B-2.18 B-2.69 B-2.74 BIngresos/gastos extraordinarios-5.61 B-2.5 B-2.45 B-4.68 B-3.24 B-5.79 B-5.79 BBeneficio antes de impuestos3.4 B12.99 B13.48 B6.25 B3.72 B6.6 B6.6 BParticipación en los beneficios———————Impuestos-1.22 B1.44 B1.63 B1.38 B-570 M2.36 B2.36 BParticipación minoritaria6 M7 M9 M10 M8 M7 M7 MOtros ingresos/gastos después de impuestos-832 M0150 M225 M63 M3 M3 MBeneficio neto antes de actividades interrumpidas4.62 B11.54 B11.84 B4.86 B4.28 B4.23 B4.23 BOperaciones suspendidas———————Beneficio neto4.62 B11.54 B11.84 B4.86 B4.28 B4.23 B4.23 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas4.56 B11.47 B11.78 B4.82 B4.24 B4.19 B4.19 BBeneficio básico por acción2.736.486.652.732.42.372.36Beneficio por acción diluido2.726.456.632.722.392.362.36Número medio de acciones ordinarias1.67 B1.77 B1.77 B1.77 B1.77 B1.77 B7.07 BAcciones diluidas1.67 B1.78 B1.78 B1.77 B1.77 B1.77 B7.09 BEBITDA17.83 B26.45 B26.58 B21.45 B17.52 B23.21 B28.87 BEBIT11.36 B17.92 B18.12 B12.76 B9.14 B15.07 B15.07 BCosto de los ingresos15.39 B17.45 B17.41 B20.41 B16.9 B18.2 B18.2 BOtros costes de producción———————Amortización y depreciación (flujo de caja)6.47 B8.52 B8.47 B8.7 B8.39 B8.14 B13.8 B
AbbVie Inc
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000.
The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'.